课题基金 / 基金详情

PFI-RP: Partnership for Innovation - Avoiding Kidney Injuries with Evidence-Based Smart Technology

PFI-RP: Partnership for Innovation - Avoiding Kidney Injuries with Evidence-Based Smart Technology
PFI-RP:创新合作——利用循证智能技术避免肾脏损伤
批准号:
2122901
负责人:
Erica Forzani
金额:
$55.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2024-08-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this Partnerships for Innovation – Research Partnerships (PFI-RP) project is to develop a new technology that improves the ability of doctors to diagnose acute kidney injury in hospitalized patients. Acute kidney injury is a medical condition which begins without clinical symptoms or signs, and has been estimated to occur in up to 20% of hospitalized patients. Acute kidney injury results in significant harm to patients as well as greatly increased overall health care costs. Acute kidney injury is generally not recognized early in its course. Currently available methods used to diagnose acute kidney injury are imperfect. Recognition of acute kidney injury using presently available methods is delayed and only occurs after the development of significant organ dysfunction. The technology that will be developed in this PFI-RP project may detect acute kidney injury earlier so that treatment can be rendered.This project will develop a new technology for continuous, real time measurement and real time analysis of urinary biomarkers of acute kidney injury. Specifically, a system for continuous measurement of urine components will be developed and built. This system will be used to measure and quantify urine components and develop a model of early acute kidney injury. A machine learning prediction model will be developed and tested with the model system.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
新型lncRNA RP11-386G11.10通过ceRNA网络调控miR-345-3p/CREB5轴促进黑色素瘤进展的机制探索
  • 批准号:
    2026JJ81952
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    党委
  • 依托单位:
LncRNA RP11介导肿瘤细胞与肺驻留型巨 噬细胞互作抑制乳腺癌肺转移的机制研 究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    罗利云
  • 依托单位:
基于患者来源类器官模型探究基因编辑技术对PRPF6突变RP疾病的作用
银杏双黄酮通过靶向鞘脂代谢异常的SPHK1+基质相关CAFs亚群以抑制S1P-S1RP3信号轴从而增敏第三代EGFR-TKIs的机制研究
  • 批准号:
    QN25H290015
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    戴淑颖
  • 依托单位: